Reply from the authors  by Garbar, Christian et al.
Letters to the Editor346
analysis of b2-microglobulin amyloid deposits identifying its in close relation with the vascular space as it is ob-
the intracellular location of amyloid fibrils [2]. We found served in many other types of amyloidosis? Where does
that intracellular b2-microglobulin amyloid fibrils were b2-microglobulin come from, as there is no b2-microglob-
almost exclusively observed in lysosomes, and there was ulin in the perivascular regions? Do amyloid deposits
no positive b2-microglobulin immunogold labeling of the exclusively arise from b2-microglobulin locally shed from
synthesis machinery of the cell, suggesting that macro- chondrocytes? Supplementary clinical, ultrastructural as
phages are not at the origin of amyloid fibrils but proba- well as biochemical studies will hopefully answer these
bly accumulate as a consequence of amyloidosis [2]. and many other questions on the pathogenesis of dial-
However, our studies also showed a wide variability in ysis-related amyloidosis.
the number of cells in different sections of a given de-
posit. Electron microscopy revealed the existence of ar-
A`ngel Argile´s and Georges Mouradeas with scarcely distributed amyloid fibrils and high cell
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nance of amyloid fibrils. Interestingly, the latter con-
Correspondence to Dr. Argile´s, CNRS IGH—UPR 1142, 141 rue detained cellular debris, suggesting the existence of cell
la Cardonille, 34396 Montpellier Cedex 5, France.death (abstract; Garcı´a-Garcı´a et al, XVth International
Congress of Nephrology, 1999). Therefore, we think that
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Reply from the authorsa role for macrophages in the genesis of Ab2M, we have
never been convinced of this point. Actually, we con- Argile´s and Mourad provide additional evidence that
cluded in that paper that, “Although much progress has macrophages are late actors in b2-microglobulin amy-
been achieved recently with the in vitro formation of loidosis (Ab2M). In their elegant immunoelectronmi-
amyloid fibrils with mononuclear cells, whether macro- croscopy study they evaluated carpal tunnel tissue sam-
phages are at the origin of this condition, or their pres- ples obtained at a late, clinically symptomatic stage [1].
ence is a consequence of it, remains to be elucidated.” Their data suggest that Ab2M deposits are actually
Our subsequent work [2] and the paper of Garbar et al phagocytized rather than synthesized by macrophages.
[1] support the hypothesis that macrophage infiltration In our study we were able to witness early stages of
is a secondary phenomenon. However, as always, should Ab2M deposition [2]. Both the fact that b2-microglobulinthis hypothesis be verified, additional questions will have amyloid was restricted to the surface of an avascular
to be answered. The first one concerns the timing of
tissue, the cartilage, and that the macrophages were ab-
the steps in the genesis of amyloidosis. Garbar et al
sent, led to the identical conclusion, that is that the pres-commented that AGEP modification of b2-microglobulin ence of macrophages is not a prerequisite for b2-micro-would attract macrophages. However, advanced glyca-
globulin amyloid formation.tion of b2-microglobulin has been proposed to be at the
Our description of three stages in Ab2M depositionorigin of amyloidosis, and macrophage infiltration would
applies only to the sternoclavicular joint. Its extensionbe a late phenomenon, only observed in stages II and
to carpal tunnel deposits is as yet unwarranted.III. Why is there such a big delay (measurable in years
Advanced glycation of b2-microglobulin might not betime) between glycation of b2-microglobulin and macro-
a prerequisite to the formation of b2M fibrils. It mightphage recruitment? Second, how can one explain that
be a late phenomenon whose extension, on previousamyloid fibrils are first deposited in an avascular tissue?
Ab2M deposits, might then reach a critical level andWouldn’t one expect to find the very first amyloid depos-
attract macrophages by chemotaxis. b2-microglobulin is
present in the joint fluid at a concentration similar to
that observed in serum [3], and might thus contribute
to amyloid formation on the cartilage independently of
chondrocytes. The mechanism of amyloid formation re- 2000 by the International Society of Nephrology
Letters to the Editor 347
mains elusive. It fortunately remains—as Argile´s and We would also note that in our experience the use
Mourad rightly point out—a topic for further interesting of brachial AV fistulae is associated with a substantial
and challenging studies. incidence of hand ischemia, particularly in diabetic pa-
tients. A policy of using primary brachial AV fistulae in
women, diabetics, and older patients as suggested byChristian Garbar, Michel Jadoul, Henri Noe¨l, and
Miller et al might produce significant complication rates.Charles van Ypersele de Strihou
Department of Pathology, A.Z. VUB, Brussels, Belgium David J. Hirsch and Kailash K. Jindal
Halifax, Canada
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Arteriovenous fistula
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adequacy We thank Drs. Hirsch and Jindal for their thoughtful
response to our publication [1].To the Editor: We were distressed by the conclusions
First, our definition of AV fistula adequacy was notof the recently published paper by Miller et al, “Pre-
totally arbitrary, but rather based on our ability to pro-dictors of adequacy of arteriovenous fistulas in hemodial-
vide adequate dialysis in a reasonable period of time.ysis patients” [1]. These authors defined an adequate
For many of our patients it was not possible to deliverarteriovenous (AV) fistula as the ability to use it for
the minimal Kt/V of 1.2 (as recommended by the NKF-hemodialysis with two needles and a blood flow of at
DOQI guidelines), with a dialysis blood flow of 200 toleast 350 mL/min on at least six dialysis sessions in one
300 mL/min, unless the dialysis time was increased sub-month. Using that definition, they drew the conclusion
stantially. At our dialysis units, it is challenging to con-that only 46.5% of fistulas develop sufficiently to be
vince many of our patients to dialyze longer than 3.5useful. They also noted that the adequacy rate was lower
hours, and exceedingly difficult to get them to stay longerin older patients and those with diabetes.
than 4 hours. Thus, settling for a low blood flow in aWe believe that there are two problems with the con-
marginal fistula in a patient who won’t dialyze longerclusions drawn by these workers.
would mean settling for suboptimal dialysis.First, this definition of AV fistula adequacy is arbi-
Second, Beathard’s study evaluated the outcomes onlytrary, although it has been used by others [2]. By increas-
for those fistulas that were referred for evaluation. Thereing the duration of dialysis, it is often possible to achieve
is no indication of how many fistulas clotted early beforeadequate dialysis clearance at blood flows less than 350
a diagnostic workup could be initiated or what propor-mL/min. This study does not report information on clear-
tion of poorly developed fistulas was referred for anance or dialysis adequacy in any of the patients. If one
evaluation. Moreover, 8 of 71 patients who were referredexpects to achieve successful dialysis with arteriovenous
underwent no further evaluation because of an inade-fistulae, it may be necessary to accept lower flow rates
quate inflow. Thus, it is likely that if one considers allwith the use of longer dialysis times.
fistulas that were placed, the salvage rate would haveA second concern with this study is the failure to
been considerably lower than that reported for the se-address the possibility of salvaging inadequate fistulae.
Beathard et al [2] indicate a significant rate of salvage lected population. In contrast, our study evaluated pro-
for inadequately functioning radiocephalic AV fistulae spectively the outcome of every fistula that was con-
using radiographic investigation and further interven- structed. Specifically, of 50 consecutive forearm fistulas
tion. Beathard and colleagues note a substantial rate of that were placed, 33 were inadequate. These included
long-term functional patency after such interventions in 14 which clotted within a few weeks of their placement.
AV fistulae. The other 19 fistulas remained patent but failed to ma-
ture adequately. Ten of these patients underwent a diag-
nostic ultrasound or fistulogram study. In seven cases an
unsuspected stenosis or occlusion of the draining vein 2000 by the International Society of Nephrology
